NR4A1 and breast cancer: The inflammatory mammary tumor microenvironment should not be confused with “inflammatory breast cancer” (IBC), a rare (1%–6% of all breast malignancies) aggressive BC subtype with higher grade metastatic hormone receptor negative tumors that has been reviewed elsewhere [25,26].